Cellular glutathione as a protective agent against 4-hydroperoxycyclophosphamide cytotoxicity in K-562 cells
@article{Peters2008CellularGA, title={Cellular glutathione as a protective agent against 4-hydroperoxycyclophosphamide cytotoxicity in K-562 cells}, author={Richard H. Peters and K. Ballard and John E. Oatis and David J. Jollow and Robert K. Stuart}, journal={Cancer Chemotherapy and Pharmacology}, year={2008}, volume={26}, pages={397-402} }
SummaryExposure of cells of the K-562 erythroleukemia cell line to 4-hydroperoxycyclophosphamide (4-HC), an analog of activated cyclophosphamide, causes a concentration-dependent inhibition of in vitro colony formation by these cells. For investigation of the role of glutathione (GSH) in the metabolism of 4-HC, GSH levels of K-562 cells were modulated by exposing the cells to buthionine sulfoximine (BSO), a specific inhibitor of GSH synthesis, and/or to GSH ethyl esters. Both the mono- and…
One Citation
Development of an assay for cellular efflux of pharmaceutically active agents and its relevance to understanding drug interactions.
- Biology, ChemistryExperimental hematology
- 2017
References
SHOWING 1-10 OF 36 REFERENCES
Glutathione depletion as a determinant of sensitivity of human leukemia cells to cyclophosphamide.
- Biology, MedicineCancer research
- 1986
The role of glutathione (GSH) as a determinant of cellular sensitivity to the cytotoxic and DNA-damaging effects of cyclophosphamide (CP) was studied in a dual culture system of rat hepatocytes and…
Effect of glutathione depletion by L-buthionine sulfoximine on the cytotoxicity of cyclophosphamide in single and fractionated doses to EMT6/SF mouse tumors and bone marrow.
- Medicine, BiologyJournal of the National Cancer Institute
- 1987
A possible role for BSO as a clinical chemosensitizer, which could be combined with fractionated doses of CYC and may be effective on small cancerous lesions is suggested.
Role of glutathione in the metabolism-dependent toxicity and chemotherapy of cyclophosphamide.
- Biology, ChemistryCancer research
- 1981
Acrolein in vivo preferentially reacts with glutathione, and sulfhydryl-containing compounds may protect against acrolein toxicity and at the same time not interfere with the chemotherapeutic activity of CP.
Protective role of thiols in cyclophosphamide-induced urotoxicity and depression of hepatic drug metabolism.
- Medicine, BiologyCancer research
- 1982
Administration of N-acetylcysteine or sodium-2-mercaptoethane sulfonate with cyclophosphamide, while not protecting against leukopenia, protected against the enzymatic inactivation and urotoxicity.
Pharmacokinetics and metabolism of sodium 2-mercaptoethanesulfonate in the rat.
- Biology, MedicineCancer research
- 1983
The formation of the pharmacologically active thiol form from dimesna is associated with the consumption of equimolar concentrations of reduced glutathione.
Synthesis and preliminary antitumor evaluation of 4-(SR)-sulfido-cyclophosphamides
- ChemistryCancer Chemotherapy and Pharmacology
- 2004
A preliminary evaluation of the curative effect after a single IV injection of 4-(S-ethane)-and 4-ethanol)-sulfidocyclophosphamide in rats bearing Yoshida ascites sarcoma or in nu/nu mice bearing human breast carcinoma xenografts suggested that these sulfido derivatives possess the same oncostatic efficacy as activated cycloph phosphamide itself.
Glutathione monoethyl ester: preparation, uptake by tissues, and conversion to glutathione.
- BiologyArchives of biochemistry and biophysics
- 1985
Inhibition of the protective effect of cyclophosphamide by pre-treatment with buthionine sulfoximine.
- Biology, MedicineInternational journal of radiation oncology, biology, physics
- 1986
Combinations of 4-hydroperoxycyclophosphamide (4-HC) and cisplatin for bone marrow purging in autologous marrow transplantation: an update.
- Biology, MedicineProgress in clinical and biological research
- 1990
At concentrations resulting in equivalent toxicity to marrow CFU-GM, cisplatin seemed to be more toxic to murine spleen blast colony forming cells (CFC-BC) than 4-HC, and the drugs in combination appeared to have at least additive toxicities against CFC- BC.
Studies on the in vivo formation of acrolein: 3-hydroxy-propylmercapturic acid as an index of cyclophosphamide (NSC-26271) activation.
- Biology, ChemistryCancer treatment reports
- 1976
3-Hydroxypropylmercapturic acid (MCA) has been quantitatively determined in the urine of rats given cyclophosphamide (CP), related antineoplastic agents, allyl alcohol, or acrolein, with a simple…